Comparative cardiac effects of halofantrine and chloroquine plus chlorpheniramine in children with acute uncomplicated falciparum malaria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 1, 1999, Pages 78-83

  Sowunmi, A ^a,b   Fehintola, F A ^a   Ogundahunsi, O A T ^a   Ofi, A B ^a   Happi, T C ^a   Oduola, A M J ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Cardiotoxicity; Chemotherapy; Children; Chloroquine chlorpheniramine; Halofantrine; Malaria; Nigeria; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CHLORPHENIRAMINE; HALOFANTRINE;

ADOLESCENT; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR EFFECT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALARIA FALCIPARUM; MALE; PATIENT MONITORING; PLASMODIUM FALCIPARUM; PR INTERVAL; QT INTERVAL; RISK; SYMPTOM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0033012579     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90189-X     Document Type: Article

References (32)

1. Abu-Aisha, H., Abu-Sabaa, H. M. A. & Nur, T. (1979). Cardiac arrest after intravenous chloroquine injection. Journal of Tropical Medicine and Hygiene, 82, 36-37.
2. Anonymous (1994). EpiInfo Version 6, A word processing database, and statistics program for public health on IBM-compatible microcomputer. Atlanta, Georgia: Centers for Disease Control and Prevention and Geneva: World Health Organization.
3. Basco, L. K. & Le Bras, J. (1994). In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum. Japanese Journal of Medical Science and Biology, 47, 59-63.
4. Bazett, H. C. (1920). An analysis of time relations of electrocardiograms. Heart, 7, 353-370.
5. Bustos, M. D. G., Gay, F., Diquet, B., Thomare, P. & Warot, D. (1994). The pharmacokinetic and electrocardiographic effects of chloroquine in healthy subjects. Tropical Medicine and Parasitology, 45, 83-86.
6. Castot, A., Rapoport, P. & Le Coz, P. (1993). Prolonged QT interval with halofantrine. Lancet, 341, 1541.
7. Garson, A. (1983). The Electrocardiogram in Infants and Children: a Systematic Approach. Philadelphia: Lea & Febiger.
8. Hien, T. T. & White, N. J. (1993). Qinghaosu. Lancet, 341, 603-608.
9. Karbwang, J., Na Bangchang, K., Bunnag, D. & Harinasuta, T. (1993). Cardiac effects of halofantrine. Lancet, 342, 501.
10. Krikler, D. M. & Curry, P. V. L. (1976). Torsade de pointes, an atypical ventricular tachycardia. British Heart Journal, 38, 117-120.
11. Lindquist, M. & Edwards, I. R. (1997). Risks of non-sedating antihistamines. Lancet, 349, 1322.
12. Matson, P. A., Luby, S. P., Redd, S. C., Rolka, H. R. & Meriwhether, R. A. (1996). Cardiac effects of standard-dose halofantrine therapy. American Journal of Tropical Medicine and Hygiene, 54, 229-231.
13. Monlun, E., Pillet, O., Cochard, J. F., Favarel-Guarrigues, J. Cl. & Le Bras, M. (1993). Prolonged QT interval with halofantrine. Lancet, 341, 1541-1542.
14. Monlun, E., Le Metayer, P., Szwandt, S., Neau, D., Longy-Boursier, M. & Horton, J. (1995). Cardiac complications of halofantrine: a prospective study of 20 patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 430-433.
15. Nosten, F., ter Kuile, F. O., Luxemburger, C., Woodrow, C., Kyle, D. E., Chongsuphajaisiddhi, T. & White, N. J. (1993). Cardiac effects of antimalarial treatment with halofantrine. Lancet, 341, 1054-1056.
16. Oduola, A. M. J., Sowunmi, A., Milhous, W. K., Brewer, T., Kyle, D. E., Gerena, L., Rossan, R., Salako, L. A. & Schuster, B. G. (1998). In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. American Journal of Tropical Medicine and Hygiene, 58, 625-629.
17. Olatunde, I. A. (1970). Parenteral chloroquine in children. West African Medical Journal, 19, 93-99.
18. Omitowoju, G. O., Ogundahunsi, O. A. T., Milhous, W. K., Gerena, L., Sowunmi, A., Schuster, B. G. & Oduola, A. M. J. (1992). Chlorpheniramine: a resistance reversing agent with potential clinical application. American Journal of Tropical Medicine and Hygiene, 47, supplement, 175 [abstract].
19. Park, M. K. & Guntheroth, W. G. (1992). How to Read Pediatric ECGs. St Louis: Mosby Year Book.
20. Phillips, R. E., Warrell, D. A., White, N. J., Looaresuwan, S. & Karbwang, J. (1985). Intravenous quinidine for the treatment of severe falciparum malaria: clinical and pharmacokinetic studies. New England Journal of Medicine, 312, 1273-1278.
21. Sowunmi, A. (1996). Renal function in acute falciparum malaria. Archives of Disease in Childhood, 73, 293-298.
22. Sowunmi, A. & Oduola, A. M. J. (1997). Comparative efficacy of chloroquine-chlorpheniramine combination and mefloquine in chloroquine-resistant Plasmodium falciparum malaria in Nigerian children. Transactions of Royal Society of Tropical Medicine and Hygiene, 91, 689-693.
23. Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T., Falade, C. O., Gbotosho, G. O. & Salako, L. A. (1997a). Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 63-67.
24. Sowunmi, A., Oduola, A. M., Ogundahunsi, A., Fehintola, F. A. & Salako, L. A. (1997b). Pharmacokinetic interactions of chlorpheniramine and chloroquine in volunteers from Nigeria. American Journal of Tropical Medicine and Hygiene, 57, supplement, 102-103 [abstract].
25. Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T. & Salako, L. A. (1998a). Enhancement of the antimalarial effect of chloroquine by chlorpheniramine in vivo. Tropical Medicine and International Health, 3, 177-183.
26. Sowunmi, A., Oduola, A. M. J., Ogundahunsi, O. A. T. & Salako, L. A. (1998b). Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 77-81.
27. Sowunmi, A., Falade, C. O., Oduola, A. M. J., Ogundahunsi, O. A. T., Fehintola, F. A., Gbotosho, G. O., Larcier, P. & Salako, L. A. (1998c). Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 446-448.
28. Touze, J. E., Bernard, J., Keundjian, A., Imbert, P., Viguier, A., Chaudet, H. & Doury, J. C. (1996). Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. American Journal of Tropical Medicine and Hygiene, 54, 225-228.
29. Tuboku-Metager, A. F. (1964). Chemotherapy of malaria. British Medical Journal, i, 1378.
30. von Seidlein, L., Jaffar, S. & Greenwood, B. (1997). Prolongation of the QTc interval in African children treated for falciparum malaria. American Journal of Tropical Medicine and Hygiene, 56, 494-497.
31. White, N. J., Looaresuwan, S. & Warrell, D. A. (1983). Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. Journal of Cardiovascular Pharmacology, 5, 173-175.
32. WHO (1990). Severe and complicated malaria (2nd edition). Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, supplement 2.